Camptothecin Efficacy to Poison Top1 Is Altered by Bisphenol A in Mouse Embryonic Fibroblasts.

Bisphenol A (BPA) is used heavily in the production of polycarbonate plastics, thermal receipt paper, and epoxies. Ubiquitous exposure to BPA has been linked to obesity, diabetes, and breast and reproductive system cancers. Resistance to chemotherapeutic agents has also been shown in cancer cell models. Here, we investigated BPA's ability to confer resistance to camptothecin (CPT) in mouse embryonic fibroblasts (MEFs). MEFs are sensitive to CPT; however, co-exposure of BPA with CPT improved cell survival. Co-exposure significantly reduced Top1-DNA adducts, decreasing chromosomal aberrations and DNA strand break formation. This decrease occurs despite BPA treatment increasing the protein levels of Top1. By examining chromatin structure after BPA exposure, we determined that widespread compaction and loss of nuclear volume occurs. Therefore, BPA reduced CPT activity by reducing the accessibility of DNA to Top1, inhibiting DNA adduct formation, the generation of toxic DNA strand breaks, and improving cell survival.

[1]  Kristine L Witt,et al.  Next generation high throughput DNA damage detection platform for genotoxic compound screening , 2018, Scientific Reports.

[2]  G. Falco,et al.  Carcinogenic risk and Bisphenol A exposure: A focus on molecular aspects in endoderm derived glands , 2017, Molecular and Cellular Endocrinology.

[3]  D. Zalko,et al.  In vitro and in vivo estrogenic activity of BPA, BPF and BPS in zebrafish-specific assays. , 2017, Ecotoxicology and environmental safety.

[4]  H. Richly,et al.  Regulation of DNA Repair Mechanisms: How the Chromatin Environment Regulates the DNA Damage Response , 2017, International journal of molecular sciences.

[5]  H. Scherthan,et al.  NAC ameliorates dental composite-induced DNA double-strand breaks and chromatin condensation. , 2017, Dental materials journal.

[6]  C. Sørensen,et al.  Chromatin Dynamics in Genome Stability: Roles in Suppressing Endogenous DNA Damage and Facilitating DNA Repair , 2017, International journal of molecular sciences.

[7]  M. Thakur,et al.  Effect of perinatal exposure to Bisphenol-A on DNA methylation and histone acetylation in cerebral cortex and hippocampus of postnatal male mice. , 2017, The Journal of toxicological sciences.

[8]  Natalie R. Gassman.  Induction of oxidative stress by bisphenol A and its pleiotropic effects , 2017, Environmental and molecular mutagenesis.

[9]  Shibin Ding,et al.  Long-term exposure to a ‘safe’ dose of bisphenol A reduced protein acetylation in adult rat testes , 2017, Scientific Reports.

[10]  C. Corcini,et al.  Maternal Transfer of Bisphenol A During Nursing Causes Sperm Impairment in Male Offspring , 2016, Archives of Environmental Contamination and Toxicology.

[11]  J. Mill,et al.  Bisphenol A causes reproductive toxicity, decreases dnmt1 transcription, and reduces global DNA methylation in breeding zebrafish (Danio rerio) , 2016, Epigenetics.

[12]  Samuel H. Wilson,et al.  Combined Effects of High-Dose Bisphenol A and Oxidizing Agent (KBrO3) on Cellular Microenvironment, Gene Expression, and Chromatin Structure of Ku70-deficient Mouse Embryonic Fibroblasts , 2016, Environmental health perspectives.

[13]  J. Lieb,et al.  Genome-wide kinetics of DNA excision repair in relation to chromatin state and mutagenesis , 2016, Proceedings of the National Academy of Sciences.

[14]  E. Ribeiro-Varandas,et al.  Bisphenol A at the reference level counteracts doxorubicin transcriptional effects on cancer related genes in HT29 cells. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[15]  D. Naiman,et al.  Temporal trends in bisphenol A exposure in the United States from 2003-2012 and factors associated with BPA exposure: Spot samples and urine dilution complicate data interpretation. , 2015, Environmental research.

[16]  S. D. de Solla,et al.  Plasticizer endocrine disruption: Highlighting developmental and reproductive effects in mammals and non-mammalian aquatic species. , 2015, General and comparative endocrinology.

[17]  R. Zoeller,et al.  NIEHS/FDA CLARITY-BPA research program update , 2015, Reproductive toxicology.

[18]  Jone Corrales,et al.  Global Assessment of Bisphenol A in the Environment , 2015, Dose-response : a publication of International Hormesis Society.

[19]  M. Hu,et al.  Effects of Low-Dose Bisphenol A on DNA Damage and Proliferation of Breast Cells: The Role of c-Myc , 2015, Environmental health perspectives.

[20]  Jingying Zhu,et al.  MAPK and NF-κB Pathways Are Involved in Bisphenol A-Induced TNF-α and IL-6 Production in BV2 Microglial Cells , 2015, Inflammation.

[21]  Samuel H. Wilson,et al.  Bisphenol A Promotes Cell Survival Following Oxidative DNA Damage in Mouse Fibroblasts , 2015, PloS one.

[22]  Jun Du,et al.  Signaling related with biphasic effects of bisphenol A (BPA) on Sertoli cell proliferation: a comparative proteomic analysis. , 2014, Biochimica et biophysica acta.

[23]  C. Bielajew,et al.  Bisphenol-A: Epigenetic Reprogramming and Effects on Reproduction and Behavior , 2014, International journal of environmental research and public health.

[24]  H. Liu,et al.  Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells. , 2014, Toxicology letters.

[25]  N. Gharbi,et al.  Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. , 2014, Environment international.

[26]  J. Rochester.  Bisphenol A and human health: a review of the literature. , 2013, Reproductive toxicology.

[27]  Yan Wang,et al.  Melatonin ameliorates bisphenol A-induced DNA damage in the germ cells of adult male rats. , 2013, Mutation research.

[28]  N. Zaffaroni,et al.  Camptothecin resistance in cancer: insights into the molecular mechanisms of a DNA-damaging drug. , 2013, Current medicinal chemistry.

[29]  C. Watson,et al.  Mixtures of xenoestrogens disrupt estradiol-induced non-genomic signaling and downstream functions in pituitary cells , 2013, Environmental Health.

[30]  N. Maizels,et al.  A rapid and sensitive assay for DNA–protein covalent complexes in living cells , 2013, Nucleic acids research.

[31]  M. Claville,et al.  Prooxidant actions of bisphenol A (BPA) phenoxyl radicals: implications to BPA-related oxidative stress and toxicity , 2013, Toxicology mechanisms and methods.

[32]  M. Dobrzyńska,et al.  Genotoxicity and reproductive toxicity of bisphenol A and X-ray/bisphenol A combination in male mice , 2013, Drug and chemical toxicology.

[33]  L. Huc,et al.  Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[34]  A. Chalmers,et al.  DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets. , 2012, Current medicinal chemistry.

[35]  Yan Zhou,et al.  Expression and DNA methylation changes in human breast epithelial cells after bisphenol A exposure. , 2012, International journal of oncology.

[36]  L. Rozek,et al.  Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A , 2012, Environmental and molecular mutagenesis.

[37]  K. Park,et al.  Bisphenol A Impairs Mitochondrial Function in the Liver at Doses below the No Observed Adverse Effect Level , 2012, Journal of Korean medical science.

[38]  Laura N. Vandenberg,et al.  Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. , 2012, Ciencia & saude coletiva.

[39]  D. Zalko,et al.  Use of the γH2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines , 2011, Archives of Toxicology.

[40]  P. Fu,et al.  Ubiquity of bisphenol A in the atmosphere. , 2010, Environmental pollution.

[41]  E. Cavalieri,et al.  Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol? , 2010, IUBMB life.

[42]  H. Taylor,et al.  In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast Cancer , 2010, Hormones & cancer.

[43]  B. Epe,et al.  Oxidative stress triggers the preferential assembly of base excision repair complexes on open chromatin regions , 2010, Nucleic acids research.

[44]  Yves Pommier,et al.  Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA‐PK , 2009, The EMBO journal.

[45]  A. Haas,et al.  Hdm2 is an Ubiquitin Ligase of Ku70 -Akt Promotes Cell Survival by Inhibiting Hdm2-dependent Ku70 Destabilization , 2008, Cell Death and Differentiation.

[46]  A. Houtsmuller,et al.  Chromatin structure and DNA damage repair , 2008, Epigenetics & Chromatin.

[47]  S. Fox,et al.  Bisphenol A at Low Nanomolar Doses Confers Chemoresistance in Estrogen Receptor-α–Positive and –Negative Breast Cancer Cells , 2008, Environmental health perspectives.

[48]  R. Jirtle,et al.  Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development , 2007, Proceedings of the National Academy of Sciences.

[49]  Laura N. Vandenberg,et al.  Human exposure to bisphenol A (BPA). , 2007, Reproductive toxicology.

[50]  Y. Pommier.  Topoisomerase I inhibitors: camptothecins and beyond , 2006, Nature Reviews Cancer.

[51]  Frederick S vom Saal,et al.  Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. , 2006, Endocrinology.

[52]  F. Palitti,et al.  Chromosomal aberrations and genomic instability induced by topoisomerase-targeted antitumour drugs. , 2004, Current medicinal chemistry. Anti-cancer agents.

[53]  K. Kohn,et al.  Repair of and checkpoint response to topoisomerase I-mediated DNA damage. , 2003, Mutation research.

[54]  L. Liu,et al.  Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells. , 2001, Cancer research.

[55]  C. Meisel,et al.  Molecular Genetics of Cancer Susceptibility , 2000, Pharmacology.

[56]  L. Liu,et al.  SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  J. Holden,et al.  The CHO XRCC1 mutant, EM9, deficient in DNA ligase III activity, exhibits hypersensitivity to camptothecin independent of DNA replication. , 1998, Mutation research.

[58]  G. Batist,et al.  Potential for selective modulation of glutathione in cancer chemotherapy. , 1998, Chemico-biological interactions.

[59]  Leroy F. Liu,et al.  Mechanism of Action of Camptothecin , 1996, Annals of the New York Academy of Sciences.

[60]  Samuel H. Wilson,et al.  Requirement of mammalian DNA polymerase-β in base-excision repair , 1996, Nature.

[61]  J. Svejstrup,et al.  New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site. , 1991, Journal of molecular biology.

[62]  L. Liu,et al.  Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. , 1990, Cancer research.

[63]  L. Liu,et al.  DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. , 1989, Science.

[64]  L. Liu,et al.  Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. , 1989, Cancer research.

[65]  R. Hertzberg,et al.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. , 1989, Biochemistry.

[66]  L. Liu,et al.  Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. , 1988, Cancer research.

[67]  R. Hertzberg,et al.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. , 1985, The Journal of biological chemistry.

[68]  W. B. Butler,et al.  Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle. , 1984, Analytical biochemistry.

[69]  G. Prins,et al.  A review of the carcinogenic potential of bisphenol A. , 2016, Reproductive toxicology.

[70]  Y. Pommier,et al.  Repair of topoisomerase I-mediated DNA damage. , 2006, Progress in nucleic acid research and molecular biology.

[71]  B. Han,et al.  Multidrug resistance in cancer chemotherapy and xenobiotic protection mediated by the half ATP-binding cassette transporter ABCG2. , 2004, Current medicinal chemistry. Anti-cancer agents.

[72]  J. Holme,et al.  Estrogen-like properties of brominated analogs of bisphenol A in the MCF-7 human breast cancer cell line , 2004, Cell Biology and Toxicology.

[73]  P. Mosesso,et al.  The involvement of chromatin condensation in camptothecin-induced chromosome breaks in G0 human lymphocytes. , 1999, Mutagenesis.

[74]  P. Hanawalt,et al.  The anti-cancer drug camptothecin inhibits elongation but stimulates initiation of RNA polymerase II transcription. , 1996, Carcinogenesis.

[75]  L. Liu,et al.  A model for tumor cell killing by topoisomerase poisons. , 1990, Cancer cells.